We have developed a model of the human blood-brain barrier (BBB) using autologous endothelial cells (EC) and astrocytes obtained from human fetuses. This model system has provided information about the functioning of the BBB during inflammatory conditions. It has also permitted the development of new hypotheses about how BBB EC may play a pivotal role in the pathogenesis of HIV CNS disease. Our focus is on the expression of EC adhesion molecules and the role of cytokines in this process. An understanding of these issues will provide information about the underlying pathologic mechanisms of CNS disease during HIV infection and may present a strategy to interrupt the process. The specific hypothesis to be tested in this proposal is that adhesion molecule expression by BBB EC facilitates the binding, and subsequent extravasation into the CNS parenchyma, of HIV-infected cells. Additionally, the adhesion of infected cells to the vasculature may result in EC infection. The role of adhesion molecules expressed by EC during inflammatory conditions is now recognized. Also, a role for adhesion molecules expressed by EC in the pathogenesis of AIDS has been suggested. However, the definition of a role for adhesion molecules in CNS disease during fetal HIV infection and pediatric AIDS remains to be established. This proposal is designed to investigate our hypothesis by using cell and molecular biologic techniques combined with microscopy and immunocytochemistry. The following studies will be conducted: 1) to characterize further this model of the BBB with respect to its structural properties, adhesion molecule expression, and the role of cytokines and HIV as inducers of adhesion molecules; 2) to determine whether the adhesion molecules under study in the BBB model system are expressed in vivo 3) to determine the mechanisms of binding and transmigration of HIV-infected and noninfected mononuclear cells through the BBB using this model, 4) to determine whether EC, cocultured with autologous astrocytes, can be infected with cell-associated virus; 5) to examine the effect of HIV, either cell-associated or cell-free, on the structure and function of EC in this co-culture model; and, 6) to examine the induction of cytokine expression by cells of this model in response to exogenous cytokines, HIV-infected mononuclear cells or cell-free virus.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH052974-04
Application #
2430984
Study Section
Psychobiological, Biological, and Neurosciences Subcommittee (MHAI)
Project Start
1994-09-30
Project End
1998-08-31
Budget Start
1997-07-01
Budget End
1998-08-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Pathology
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Roberts, Toni K; Eugenin, Eliseo A; Morgello, Susan et al. (2010) PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation. Am J Pathol 177:1848-60
Eugenin, Eliseo A; Morgello, Susan; Klotman, Mary E et al. (2008) Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. Am J Pathol 172:1100-11
Eugenin, Eliseo A; King, Jessie E; Nath, Avindra et al. (2007) HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc Natl Acad Sci U S A 104:3438-43
King, J E; Eugenin, E A; Buckner, C M et al. (2006) HIV tat and neurotoxicity. Microbes Infect 8:1347-57
Calderon, Tina M; Eugenin, Eliseo A; Lopez, Lillie et al. (2006) A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J Neuroimmunol 177:27-39
Buckner, Clarisa M; Luers, Aimee J; Calderon, Tina M et al. (2006) Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. J Neuroimmune Pharmacol 1:160-81
D'Aversa, T G; Eugenin, E A; Berman, J W (2005) NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation. J Neurosci Res 81:436-46
D'Aversa, Teresa G; Yu, Karl O A; Berman, Joan W (2004) Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J Neurovirol 10:86-97
Eugenin, E A; D'Aversa, T G; Lopez, L et al. (2003) MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 85:1299-311
Ma, Harry; Calderon, Tina M; Kessel, Tamar et al. (2003) Mechanisms of hepatocyte growth factor-mediated vascular smooth muscle cell migration. Circ Res 93:1066-73

Showing the most recent 10 out of 26 publications